Skip to main content

Kiniksa Pharmaceuticals International, plc 10-Q for FY2025 Q3

Kiniksa Pharmaceuticals International, plc (KNSA)

10-Q 2025-10-28 For: 2025-09-30
View Original
Added on April 04, 2026

About this 10-Q

Kiniksa Pharmaceuticals International, plc filed this 10-Q on October 28, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$180.86M
up 61.2% from $112.21M a year earlier
Net income
$18.44M
compared with a net loss of $12.69M a year earlier
Diluted EPS
$0.23
compared with -$0.18 a year earlier